New Market Study: "Prescribing Influences: Schizophrenia - Plethora of antipsychotics fail to address negative symptoms"
Datamonitor conducted a primary research survey of 140 psychiatrists across the seven major markets on their schizophrenia treatment choices and prescribing habits. A greater understanding of unmet needs and the factors that influence the prescription of drugs will aid companies in effectively positioning their treatments in the increasingly competitive schizophrenia market.
View full press release